China Universal Asset Management »

Ambrx Biopharma shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Ambrx Biopharma shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Ambrx Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Ambrx Biopharma held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ambrx Biopharma by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $104k 7.3k 14.24

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Ambrx Biopharma

Darwin Global Management
Cormorant Asset Management
Paradigm Biocapital Advisors
D. E. Shaw & Co
Nextech Invest
Balyasny Asset Management
Citadel Advisors
Logos Global Management
VR Adviser
Vanguard Group
T. Rowe Price Associates
Millennium Management
Goldman Sachs Group
Federated Investors
OrbiMed Advisors

View all funds holding Ambrx Biopharma